Literature DB >> 21503283

Suitability of porous silicon microparticles for the long-term delivery of redox-active therapeutics.

Elizabeth C Wu1, Jennifer S Andrew, Alex Buyanin, Joseph M Kinsella, Michael J Sailor.   

Abstract

Thermal oxidation of porous Si microparticles provides an inert carrier for the long-term release of the anthracycline drug daunorubicin. Without prior oxidation, porous Si undergoes an undesirable side reaction with this redox active drug. © The Royal Society of Chemistry 2011

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21503283     DOI： 10.1039/c1cc10993f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  11 in total

1.  Intravitreal controlled release of dexamethasone from engineered microparticles of porous silicon dioxide.

Authors:  Chengyun Wang; Huiyuan Hou; Kaihui Nan; Michael J Sailor; William R Freeman; Lingyun Cheng
Journal:  Exp Eye Res       Date:  2014-11-05       Impact factor: 3.467

2.  Surface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.

Authors:  Alejandra Nieto; Huiyuan Hou; Sang Woong Moon; Michael J Sailor; William R Freeman; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-22       Impact factor: 4.799

3.  Porous silicon pillar structures/photosynthetic reaction centre protein hybrid for bioelectronic applications.

Authors:  Kata Hajdu; R Fabiola Balderas-Valadez; Alessandro Carlino; Vivechana Agarwal; László Nagy
Journal:  Photochem Photobiol Sci       Date:  2021-10-30       Impact factor: 3.982

4.  Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.

Authors:  Biana Godin; Ciro Chiappini; Srimeenakshi Srinivasan; Jenolyn F Alexander; Kenji Yokoi; Mauro Ferrari; Paolo Decuzzi; Xuewu Liu
Journal:  Adv Funct Mater       Date:  2012-10-23       Impact factor: 18.808

5.  Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin.

Authors:  Kathrin I Hartmann; Alejandra Nieto; Elizabeth C Wu; William R Freeman; Jae Suk Kim; Jay Chhablani; Michael J Sailor; Lingyun Cheng
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-28       Impact factor: 2.671

6.  Tunable sustained intravitreal drug delivery system for daunorubicin using oxidized porous silicon.

Authors:  Huiyuan Hou; Alejandra Nieto; Feiyan Ma; William R Freeman; Michael J Sailor; Lingyun Cheng
Journal:  J Control Release       Date:  2014-01-11       Impact factor: 9.776

7.  Protection and Delivery of Anthelmintic Protein Cry5B to Nematodes Using Mesoporous Silicon Particles.

Authors:  Chia-Chen Wu; Yan Hu; Melanie Miller; Raffi V Aroian; Michael J Sailor
Journal:  ACS Nano       Date:  2015-05-20       Impact factor: 15.881

8.  Oxidation-Induced Trapping of Drugs in Porous Silicon Microparticles.

Authors:  Nicole L Fry; Gerry R Boss; Michael J Sailor
Journal:  Chem Mater       Date:  2014-03-20       Impact factor: 9.811

9.  Bombarding cancer: biolistic delivery of therapeutics using porous Si carriers.

Authors:  Neta Zilony; Adi Tzur-Balter; Ester Segal; Orit Shefi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  Structural and Functional Hierarchy in Photosynthetic Energy Conversion-from Molecules to Nanostructures.

Authors:  Tibor Szabó; Melinda Magyar; Kata Hajdu; Márta Dorogi; Emil Nyerki; Tünde Tóth; Mónika Lingvay; Győző Garab; Klára Hernádi; László Nagy
Journal:  Nanoscale Res Lett       Date:  2015-12-01       Impact factor: 4.703
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.